15-88859008-T-C
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_001369268.1(ACAN):āc.6423T>Cā(p.Leu2141Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.773 in 1,613,796 control chromosomes in the GnomAD database, including 486,313 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.78 ( 47112 hom., cov: 32)
Exomes š: 0.77 ( 439201 hom. )
Consequence
ACAN
NM_001369268.1 synonymous
NM_001369268.1 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.81
Genes affected
ACAN (HGNC:319): (aggrecan) This gene is a member of the aggrecan/versican proteoglycan family. The encoded protein is an integral part of the extracellular matrix in cartilagenous tissue and it withstands compression in cartilage. Mutations in this gene may be involved in skeletal dysplasia and spinal degeneration. Multiple alternatively spliced transcript variants that encode different protein isoforms have been observed in this gene. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.03).
BP6
Variant 15-88859008-T-C is Benign according to our data. Variant chr15-88859008-T-C is described in ClinVar as [Benign]. Clinvar id is 1188994.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr15-88859008-T-C is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=-1.81 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.841 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ACAN | NM_001369268.1 | c.6423T>C | p.Leu2141Leu | synonymous_variant | 12/19 | ENST00000560601.4 | NP_001356197.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ACAN | ENST00000560601.4 | c.6423T>C | p.Leu2141Leu | synonymous_variant | 12/19 | 3 | NM_001369268.1 | ENSP00000453581.2 |
Frequencies
GnomAD3 genomes AF: 0.785 AC: 119292AN: 152052Hom.: 47083 Cov.: 32
GnomAD3 genomes
AF:
AC:
119292
AN:
152052
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.730 AC: 181887AN: 249080Hom.: 67644 AF XY: 0.733 AC XY: 99039AN XY: 135168
GnomAD3 exomes
AF:
AC:
181887
AN:
249080
Hom.:
AF XY:
AC XY:
99039
AN XY:
135168
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.772 AC: 1128855AN: 1461626Hom.: 439201 Cov.: 83 AF XY: 0.770 AC XY: 559774AN XY: 727092
GnomAD4 exome
AF:
AC:
1128855
AN:
1461626
Hom.:
Cov.:
83
AF XY:
AC XY:
559774
AN XY:
727092
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.784 AC: 119371AN: 152170Hom.: 47112 Cov.: 32 AF XY: 0.774 AC XY: 57600AN XY: 74398
GnomAD4 genome
AF:
AC:
119371
AN:
152170
Hom.:
Cov.:
32
AF XY:
AC XY:
57600
AN XY:
74398
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2352
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Spondyloepimetaphyseal dysplasia, aggrecan type Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jul 14, 2021 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Osteochondritis dissecans Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jul 14, 2021 | - - |
Spondyloepiphyseal dysplasia, Kimberley type Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jul 14, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at